Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.
2.

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption.

Moosavi M, Zarifkar AH, Farbood Y, Dianat M, Sarkaki A, Ghasemi R.

Eur J Pharmacol. 2014 Aug 5;736:107-14. doi: 10.1016/j.ejphar.2014.03.041.

PMID:
24769303
3.

Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.

Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H.

Neurol Sci. 2014 May;35(5):741-51. doi: 10.1007/s10072-013-1594-3.

PMID:
24337945
4.
5.

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.

Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S.

J Alzheimers Dis. 2010;19(2):691-704. doi: 10.3233/JAD-2010-1270.

PMID:
20110613
6.

Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.

Chen S, An FM, Yin L, Liu AR, Yin DK, Yao WB, Gao XD.

Neuroscience. 2014 Jan 3;256:137-46. doi: 10.1016/j.neuroscience.2013.10.038.

PMID:
24183963
7.

Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.

Xian YF, Mao QQ, Wu JC, Su ZR, Chen JN, Lai XP, Ip SP, Lin ZX.

J Alzheimers Dis. 2014;39(2):331-46. doi: 10.3233/JAD-131457.

PMID:
24164737
8.

FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.

Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D.

PLoS One. 2013 Nov 4;8(11):e78033. doi: 10.1371/journal.pone.0078033.

9.

Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.

Cai HY, Hölscher C, Yue XH, Zhang SX, Wang XH, Qiao F, Yang W, Qi JS.

Neuroscience. 2014 Sep 26;277:6-13. doi: 10.1016/j.neuroscience.2014.02.022.

PMID:
24583037
10.

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.

Xu W, Yang Y, Yuan G, Zhu W, Ma D, Hu S.

J Investig Med. 2015 Feb;63(2):267-72. doi: 10.1097/JIM.0000000000000129.

PMID:
25479064
11.

Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.

Kosaraju J, Gali CC, Khatwal RB, Dubala A, Chinni S, Holsinger RM, Madhunapantula VS, Muthureddy Nataraj SK, Basavan D.

Neuropharmacology. 2013 Sep;72:291-300. doi: 10.1016/j.neuropharm.2013.04.008.

PMID:
23603201
12.
14.

AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.

Du LL, Chai DM, Zhao LN, Li XH, Zhang FC, Zhang HB, Liu LB, Wu K, Liu R, Wang JZ, Zhou XW.

J Alzheimers Dis. 2015;43(3):775-84. doi: 10.3233/JAD-140564.

PMID:
25114075
15.

Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.

Park SJ, Kim YH, Nam GH, Choe SH, Lee SR, Kim SU, Kim JS, Sim BW, Song BS, Jeong KJ, Lee Y, Park YI, Lee KM, Huh JW, Chang KT.

Int J Mol Sci. 2015 Jan 22;16(2):2386-402. doi: 10.3390/ijms16022386.

16.

Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.

Barilar JO, Knezovic A, Grünblatt E, Riederer P, Salkovic-Petrisic M.

J Neural Transm (Vienna). 2015 Apr;122(4):565-76. doi: 10.1007/s00702-014-1323-y.

PMID:
25503661
17.

Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.

Ren QG, Wang YJ, Gong WG, Xu L, Zhang ZJ.

J Alzheimers Dis. 2015;47(1):61-71. doi: 10.3233/JAD-143012.

PMID:
26402755
18.
19.

Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats.

Liu P, Zou LB, Wang LH, Jiao Q, Chi TY, Ji XF, Jin G.

Psychopharmacology (Berl). 2014 Jan;231(2):345-56.

PMID:
23958944
20.

Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.

Kamat PK, Rai S, Swarnkar S, Shukla R, Ali S, Najmi AK, Nath C.

Neuroscience. 2013 May 15;238:97-113. doi: 10.1016/j.neuroscience.2013.01.075.

PMID:
23415789
Items per page

Supplemental Content

Support Center